[Federal Register Volume 86, Number 61 (Thursday, April 1, 2021)]
[Notices]
[Pages 17164-17165]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-06705]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2021-N-0262]


Food and Drug Administration Science Forum 2021; Public Workshop

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public workshop.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA, Agency, or we) is 
announcing the following virtual public workshop entitled ``FDA Science 
Forum 2021.'' The purpose of the public workshop is to inform the 
public about the groundbreaking science conducted at the Agency and to 
show how scientific research is used in FDA's regulatory decisions to 
protect and promote public health.

DATES: The public workshop will be held virtually on May 26, 2021 (Day 
1), from 9 a.m. to 3:30 p.m. Eastern Time, and May 27, 2021 (Day 2), 
from 9 a.m. to 2 p.m. Eastern Time. See the

[[Page 17165]]

SUPPLEMENTARY INFORMATION section for registration date and 
information.

ADDRESSES: Please note that due to the impact of the COVID-19 pandemic, 
all participants will be joining this public workshop via an online 
teleconferencing platform.

FOR FURTHER INFORMATION CONTACT: Rokhsareh Shahidzadeh, Office of 
Scientific Professional Development, Office of the Chief Scientist, 
Office of the Commissioner, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 32, Rm. 2383, Silver Spring, MD 20993, 301-796-
8740, FDASciProDev@fda.hhs.gov.

SUPPLEMENTARY INFORMATION:

I. Background

    The FDA Science Forum is held biennially to inform the public about 
the groundbreaking science conducted at the Agency and to show how 
scientific research is used in FDA's regulatory decisions to protect 
and promote public health. Open to the public, industry, academia, 
patient advocates, government agencies, and current and potential 
collaborators, the 2-day event offers an opportunity to hear FDA 
scientific experts and nationally renowned scientists speak on a range 
of topics associated with regulatory science.

II. Topics for Discussion at the Public Workshop

    The theme for the 2021 FDA Science Forum, ``Science as the 
Foundation for Protecting and Promoting Public Health'', will highlight 
areas of FDA research, including: (1) Improving clinical and postmarket 
evaluation; (2) substance use, misuse, and addiction; (3) product 
development and manufacturing; and (4) medical countermeasures, 
infectious disease, and pathogen-reduction technologies.

III. Participating in the Public Workshop

    Registration: To register for the public workshop, please visit the 
following website: https://www.fda.gov/scienceforum. Registration is 
free. Persons interested in attending this public workshop must 
register by May 21, 2021, by 5 p.m. Eastern Time. Registrants will 
receive confirmation when they have been accepted.
    If you need special accommodations due to a disability, please 
contact Rokhsareh Shahidzadeh (see FOR FURTHER INFORMATION CONTACT) no 
later than May 21, 2021, by 5 p.m. Eastern Time.
    Streaming Webcast of the Public Workshop: This public workshop will 
be streamed via a webcast only. To register for the webcast, please 
visit the following website: https://www.fda.gov/scienceforum. 
Participants interested in viewing via webcast must register by May 21, 
2021, by 5 p.m. Eastern Time.
    If you have never attended a Connect Pro event before, test your 
connection at https://collaboration.fda.gov/common/help/en/support/meeting_test.htm. To get a quick overview of the Connect Pro program, 
visit https://www.adobe.com/go/connectpro_overview. FDA has verified 
the website addresses in this document, as of the date this document 
publishes in the Federal Register, but websites are subject to change 
over time.

    Dated: March 24, 2021.
Lauren K. Roth,
Acting Principal Associate Commissioner for Policy.
[FR Doc. 2021-06705 Filed 3-31-21; 8:45 am]
BILLING CODE 4164-01-P


